EE04047B1 - Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid - Google Patents

Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid

Info

Publication number
EE04047B1
EE04047B1 EE9700240A EE9700240A EE04047B1 EE 04047 B1 EE04047 B1 EE 04047B1 EE 9700240 A EE9700240 A EE 9700240A EE 9700240 A EE9700240 A EE 9700240A EE 04047 B1 EE04047 B1 EE 04047B1
Authority
EE
Estonia
Prior art keywords
ftc
zidovudine
synergistic combinations
synergistic
combinations
Prior art date
Application number
EE9700240A
Other languages
English (en)
Other versions
EE9700240A (et
Inventor
Walter Barry David
Heider St. Clair Martha
Original Assignee
The Wellcome Foundation Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE04047(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9506489.5A external-priority patent/GB9506489D0/en
Priority claimed from GBGB9506490.3A external-priority patent/GB9506490D0/en
Application filed by The Wellcome Foundation Limited filed Critical The Wellcome Foundation Limited
Publication of EE9700240A publication Critical patent/EE9700240A/et
Publication of EE04047B1 publication Critical patent/EE04047B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EE9700240A 1995-03-30 1996-03-28 Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid EE04047B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9506489.5A GB9506489D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
GBGB9506490.3A GB9506490D0 (en) 1995-03-30 1995-03-30 Antiviral combinations
PCT/EP1996/001352 WO1996030025A1 (en) 1995-03-30 1996-03-28 Synergistic combinations of zidovudine, 1592u89 and 3tc or ftc

Publications (2)

Publication Number Publication Date
EE9700240A EE9700240A (et) 1998-04-15
EE04047B1 true EE04047B1 (et) 2003-06-16

Family

ID=26306774

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700240A EE04047B1 (et) 1995-03-30 1996-03-28 Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid

Country Status (36)

Country Link
US (1) US6417191B1 (et)
EP (1) EP0817637B1 (et)
JP (1) JP2954357B2 (et)
KR (1) KR100542536B1 (et)
CN (1) CN1103593C (et)
AP (1) AP652A (et)
AT (1) ATE220551T1 (et)
AU (1) AU715213B2 (et)
BR (3) BR9607851B1 (et)
CA (1) CA2216634C (et)
CZ (1) CZ295940B6 (et)
DE (3) DE122005000029I1 (et)
DK (1) DK0817637T3 (et)
EA (1) EA000626B3 (et)
EE (1) EE04047B1 (et)
ES (1) ES2179193T3 (et)
FR (1) FR05C0022I2 (et)
GE (1) GEP20022647B (et)
HK (1) HK1009401A1 (et)
HU (1) HU224010B1 (et)
IL (1) IL117727A (et)
LU (1) LU91171I2 (et)
MX (1) MX9707316A (et)
MY (1) MY115461A (et)
NL (1) NL300195I2 (et)
NO (2) NO313787B1 (et)
NZ (1) NZ306419A (et)
OA (1) OA10616A (et)
PL (1) PL187085B1 (et)
PT (1) PT817637E (et)
RO (1) RO117995B1 (et)
SI (1) SI0817637T1 (et)
SK (1) SK283825B6 (et)
TR (1) TR199701074T1 (et)
UA (1) UA60293C2 (et)
WO (1) WO1996030025A1 (et)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ429498A3 (cs) * 1996-06-25 1999-06-16 Glaxo Group Limited Kombinace obsahující VX478, zidovudin, FTC a/nebo 3TC pro léčbu infekce HIV
US6113920A (en) * 1996-10-31 2000-09-05 Glaxo Wellcome Inc. Pharmaceutical compositions
TW536403B (en) * 1997-03-24 2003-06-11 Glaxo Group Ltd An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy
GB9709945D0 (en) * 1997-05-17 1997-07-09 Glaxo Group Ltd A novel salt
WO1998052570A1 (en) * 1997-05-17 1998-11-26 Glaxo Group Limited Antiviral combinations containing the carbocyclic nucleoside 1592u89
AU769660B2 (en) * 1997-05-17 2004-01-29 Glaxo Group Limited Carbocyclic nucleoside hemisulfate and its use in treating viral infections
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US6875773B1 (en) 1998-05-29 2005-04-05 Ben M. Dunn Combination therapy for treatment of FIV infection
CA2374198A1 (en) * 1998-05-29 1999-12-02 Maki Arai Combination therapy for treatment of fiv infection
GB9820417D0 (en) * 1998-09-18 1998-11-11 Glaxo Group Ltd Antiviral combinations
US6432966B2 (en) 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
AP2220A (en) * 2001-05-11 2011-03-24 Cipla Medpro Pty Ltd Pharmaceutical composition.
TW200403061A (en) * 2002-06-04 2004-03-01 Glaxo Group Ltd Pharmaceutical compositions
CA2512319A1 (en) * 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AU2004224191A1 (en) 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
DE602004030369D1 (de) 2003-10-24 2011-01-13 Immunaid Pty Ltd Therapieverfahren
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
KR20080056220A (ko) 2005-10-19 2008-06-20 에프. 호프만-라 로슈 아게 페닐-아세트아마이드 ｎｎｒｔ 저해제
JP5415957B2 (ja) 2006-12-13 2014-02-12 エフ．ホフマン−ラ ロシュ アーゲー 非ヌクレオシド逆転写酵素阻害剤としての２−（ピペリジン−４−イル）−４−フェノキシ−又はフェニルアミノ−ピリミジン誘導体
WO2008095263A1 (en) * 2007-02-09 2008-08-14 Alphapharm Pty Ltd A dosage form containing two or more active pharmaceutical ingredients in different physical forms
EP2982978A1 (en) 2009-05-27 2016-02-10 Immunaid Pty Ltd Methods of treating diseases
EP3351249A1 (en) 2010-01-27 2018-07-25 VIIV Healthcare Company Antiviral therapy
MX2016002560A (es) 2013-08-29 2016-10-26 Teva Pharma Forma de dosificacion unitaria que comprende emtricitabina, tenofovir, darunavir y ritonavir y un comprimido monolitico que comprende darunavir y ritonavir.
AU2015245217A1 (en) 2014-04-08 2016-10-13 Teva Pharmaceutical Industries Ltd. Unit dosage form comprising Emtricitabine, Tenofovir, Darunavir and Ritonavir
CN117164657A (zh) 2014-08-12 2023-12-05 莫纳什大学 定向淋巴的前药
US11738087B2 (en) 2015-09-08 2023-08-29 Monash University Lymph directing prodrugs
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP4306524A2 (en) * 2017-08-29 2024-01-17 PureTech LYT, Inc. Lymphatic system-directing lipid prodrugs
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5047407A (en) 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5122517A (en) 1988-06-10 1992-06-16 Regents Of The University Of Minnesota Antiviral combination comprising nucleoside analogs
GB8815265D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Therapeutic nucleosides
US5204466A (en) 1990-02-01 1993-04-20 Emory University Method and compositions for the synthesis of bch-189 and related compounds
GB9009861D0 (en) 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
GB9104740D0 (en) 1991-03-06 1991-04-17 Wellcome Found Antiviral nucleoside combination
EP0513917B2 (en) * 1991-05-16 2001-03-07 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
DK0639971T3 (da) * 1992-05-13 2000-03-20 Wellcome Found Terapeutiske kombinationer
US5723490A (en) 1992-09-08 1998-03-03 Vertex Pharmaceuticals Incorporated THF-containing sulfonamide inhibitors of aspartyl protease
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
US5869461A (en) 1995-03-16 1999-02-09 Yale University Reducing toxicity of L-nucleosides with D-nucleosides
ATE230267T1 (de) 1996-06-25 2003-01-15 Glaxo Group Ltd Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv
CZ429498A3 (cs) 1996-06-25 1999-06-16 Glaxo Group Limited Kombinace obsahující VX478, zidovudin, FTC a/nebo 3TC pro léčbu infekce HIV
DE10226522A1 (de) * 2002-06-14 2003-12-24 Degussa Verwendung von Übergangsmetallkomplexen mit stickstoffhaltigen mehrzähnigen Liganden als Bleichkatalysator und Bleichmittelzusammensetzung

Also Published As

Publication number Publication date
NL300195I1 (nl) 2005-08-01
TR199701074T1 (xx) 1998-02-21
AU715213B2 (en) 2000-01-20
NO974510L (no) 1997-09-29
AU5497296A (en) 1996-10-16
BR9607851A (pt) 1998-07-21
IL117727A0 (en) 1996-07-23
BR9607851B1 (pt) 2009-01-13
CN1185110A (zh) 1998-06-17
LU91171I9 (et) 2018-12-28
IL117727A (en) 1999-11-30
NL300195I2 (nl) 2005-11-01
CN1103593C (zh) 2003-03-26
BRPI9607851B8 (pt) 2019-11-05
DE122005000029I2 (de) 2006-04-27
CA2216634C (en) 2004-07-20
PL322532A1 (en) 1998-02-02
DE69622386T2 (de) 2003-02-13
FR05C0022I1 (et) 2005-06-10
AP9701089A0 (en) 1997-10-31
GEP20022647B (en) 2002-03-25
BRPI9612992B1 (pt) 2020-08-04
CZ295940B6 (cs) 2005-12-14
EA000626B1 (ru) 1999-12-29
CA2216634A1 (en) 1996-10-03
LU91171I2 (fr) 2005-07-04
NO313787B1 (no) 2002-12-02
NO2005014I2 (no) 2008-02-11
EA199700203A1 (ru) 1998-02-26
US6417191B1 (en) 2002-07-09
EP0817637B1 (en) 2002-07-17
KR100542536B1 (ko) 2006-03-23
DE122005000029I1 (de) 2005-10-06
RO117995B1 (ro) 2002-12-30
SK129597A3 (en) 1998-07-08
EA000626B3 (ru) 2016-04-29
MX9707316A (es) 1997-11-29
DE69622386D1 (de) 2002-08-22
NO2005014I1 (no) 2005-06-06
SK283825B6 (sk) 2004-02-03
WO1996030025A1 (en) 1996-10-03
HK1009401A1 (en) 1999-09-10
JPH10511682A (ja) 1998-11-10
EP0817637A1 (en) 1998-01-14
FR05C0022I2 (et) 2005-10-21
EE9700240A (et) 1998-04-15
HUP9801571A2 (hu) 1999-01-28
HUP9801571A3 (en) 2001-04-28
SI0817637T1 (en) 2002-10-31
NZ306419A (en) 2000-01-28
PT817637E (pt) 2002-11-29
UA60293C2 (uk) 2003-10-15
HU224010B1 (hu) 2005-04-28
NO974510D0 (no) 1997-09-29
AP652A (en) 1998-06-19
DK0817637T3 (da) 2002-11-11
PL187085B1 (pl) 2004-05-31
ES2179193T3 (es) 2003-01-16
KR19980703420A (ko) 1998-11-05
ATE220551T1 (de) 2002-08-15
CZ309097A3 (cs) 1998-05-13
JP2954357B2 (ja) 1999-09-27
OA10616A (en) 2001-03-15
MY115461A (en) 2003-06-30

Similar Documents

Publication Publication Date Title
EE04047B1 (et) Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
DE69415157T2 (de) Elektrochirurgischer prozessor und anwendung
NL300295I2 (nl) 3,3-diarylpropylaminen, de toepassing en bereidinghiervan
FI960889A (fi) Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä
PT941056E (pt) Composicoes de esfingomielinase e sua utilizacao
DE69627513D1 (de) Kochgerät und dessen betriebsverfahren
PT1082330E (pt) Complexo de platina sua preparacao e sua aplicacao terapeutica
AU3262797A (en) Combinations comprising vx478, zidovudine, ftc and/or 3tc for use in the treatment of hiv
BR9508110A (pt) Derivado de triterpeno e composição médica
BR9611179A (pt) Composiç o em creme
PT935692E (pt) Tratamento de tecido com celulase e oxidoredutase
FI963334A (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
BR9800753B1 (pt) composição cosmética e/ou dermatológica e uso de uma composição.
PT826679E (pt) Compostos de naftilo intermediarios composicoes e metodos de utilizacao
ITMI981895A0 (it) Composizione cosmetica e/o idratante
BR9610382A (pt) Composição de tratamento do cableo
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
BR9603032A (pt) Composição pesticida
KR960026478U (ko) 골절기
FI963720A0 (fi) N-aryyli- ja N-alkyylisulfonyyliaminaalit tuholaisten torjunta-aineina
PT101949A (pt) Boneco com elevacao simultania de bracos, pernas e abertura de olhos
FI972988A0 (fi) Menetelmiä ja farmaseuttisia koostumuksia, joissa käytetään desmetyyliselegiliiniä
FI970497A0 (fi) Arrangemang foer raeddningsvaeg i en byggnad med flera vaoningar

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

FG1Y Spc granted

Free format text: PRODUCT NAME: KIVEXA; NAT. REGISTRATION NO/DATE: C(2004)5373 20041217; FIRST REGISTRATION: EU/1/04/298/001-002

Spc suppl protection certif: C20050002 00007

Filing date: 20050512

Extension date: 20191217

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

SPCM Correction and amendment to the data concerning application for a supplementary protection certificate

Spc suppl protection certif: C20050002 00007

Extension date: 20191222

SPCX Term of validity of supplementary protection expired

Spc suppl protection certif: 00007

Extension date: 20211209